RAP1A and early-onset autosomal dominant Alzheimer disease: In this way, the inhibition of Rap1 interaction with PDE6δ has been proven to be beneficial in restraining disease-associated, abnormal Ca2+ influx and neuronal hyperactivity, and providing neuroprotection in models of Alzheimer’s disease [24].